Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 4 of 4 entries
Sorted by: Best Match Show Resources per page
Development and content validation of the Satisfaction and Experience Questionnaire for Granulocyte Colony-Stimulating Factor (SEQ-G-CSF).

Journal of patient-reported outcomes

Yucel A, Skalicky A, Eseyin OR, Yucel E, Belani R, Bensink M.
PMID: 33459887
J Patient Rep Outcomes. 2021 Jan 18;5(1):10. doi: 10.1186/s41687-020-00277-8.

BACKGROUND: Several options for granulocyte colony-stimulating factor (G-CSF) prophylaxis of chemotherapy-induced febrile neutropenia are available to patients worldwide. We have developed a novel patient-reported outcome measure, the Satisfaction and Experience Questionnaire for G-CSF (SEQ-G-CSF), to help understand patients' perspectives...

Cite
Yucel A, Skalicky A, Eseyin OR, et al. Development and content validation of the Satisfaction and Experience Questionnaire for Granulocyte Colony-Stimulating Factor (SEQ-G-CSF). J Patient Rep Outcomes. 2021;5(1):10doi: 10.1186/s41687-020-00277-8.
Yucel, A., Skalicky, A., Eseyin, O. R., Yucel, E., Belani, R., & Bensink, M. (2021). Development and content validation of the Satisfaction and Experience Questionnaire for Granulocyte Colony-Stimulating Factor (SEQ-G-CSF). Journal of patient-reported outcomes, 5(1), 10. https://doi.org/10.1186/s41687-020-00277-8
Yucel, Aylin, et al. "Development and content validation of the Satisfaction and Experience Questionnaire for Granulocyte Colony-Stimulating Factor (SEQ-G-CSF)." Journal of patient-reported outcomes vol. 5,1 (2021): 10. doi: https://doi.org/10.1186/s41687-020-00277-8
Yucel A, Skalicky A, Eseyin OR, Yucel E, Belani R, Bensink M. Development and content validation of the Satisfaction and Experience Questionnaire for Granulocyte Colony-Stimulating Factor (SEQ-G-CSF). J Patient Rep Outcomes. 2021 Jan 18;5(1):10. doi: 10.1186/s41687-020-00277-8. PMID: 33459887; PMCID: PMC7813942.
Copy Download .nbib Format: NLM
Control of Low-Density Lipoprotein Cholesterol in Secondary Prevention of Coronary Artery Disease in Real-Life Practice: The DAUSSET Study in French Cardiologists.

Journal of clinical medicine

Ferrières J, Roubille F, Farnier M, Jourdain P, Angoulvant D, Boccara F, Danchin N.
PMID: 34945235
J Clin Med. 2021 Dec 17;10(24). doi: 10.3390/jcm10245938.

INTRODUCTION: Patients with established coronary artery disease (CAD) are at very high risk for cardiovascular events.METHODS: The DAUSSET study is a national, multicenter, non-interventional study that included very high-risk CAD patients followed by French cardiologists. It aimed to describe...

Cite
Ferrières J, Roubille F, Farnier M, et al. Control of Low-Density Lipoprotein Cholesterol in Secondary Prevention of Coronary Artery Disease in Real-Life Practice: The DAUSSET Study in French Cardiologists. J Clin Med. 2021;10(24)doi: 10.3390/jcm10245938.
Ferrières, J., Roubille, F., Farnier, M., Jourdain, P., Angoulvant, D., Boccara, F., & Danchin, N. (2021). Control of Low-Density Lipoprotein Cholesterol in Secondary Prevention of Coronary Artery Disease in Real-Life Practice: The DAUSSET Study in French Cardiologists. Journal of clinical medicine, 10(24), . https://doi.org/10.3390/jcm10245938
Ferrières, Jean, et al. "Control of Low-Density Lipoprotein Cholesterol in Secondary Prevention of Coronary Artery Disease in Real-Life Practice: The DAUSSET Study in French Cardiologists." Journal of clinical medicine vol. 10,24 (2021). doi: https://doi.org/10.3390/jcm10245938
Ferrières J, Roubille F, Farnier M, Jourdain P, Angoulvant D, Boccara F, Danchin N. Control of Low-Density Lipoprotein Cholesterol in Secondary Prevention of Coronary Artery Disease in Real-Life Practice: The DAUSSET Study in French Cardiologists. J Clin Med. 2021 Dec 17;10(24). doi: 10.3390/jcm10245938. PMID: 34945235; PMCID: PMC8707804.
Copy Download .nbib Format: NLM
Control of Low-Density Lipoprotein Cholesterol in Secondary Prevention of Coronary Artery Disease in Real-Life Practice: The DAUSSET Study in French Cardiologists.

Journal of clinical medicine

Ferrières J, Roubille F, Farnier M, Jourdain P, Angoulvant D, Boccara F, Danchin N.
PMID: 34945235
J Clin Med. 2021 Dec 17;10(24). doi: 10.3390/jcm10245938.

INTRODUCTION: Patients with established coronary artery disease (CAD) are at very high risk for cardiovascular events.METHODS: The DAUSSET study is a national, multicenter, non-interventional study that included very high-risk CAD patients followed by French cardiologists. It aimed to describe...

Cite
Ferrières J, Roubille F, Farnier M, et al. Control of Low-Density Lipoprotein Cholesterol in Secondary Prevention of Coronary Artery Disease in Real-Life Practice: The DAUSSET Study in French Cardiologists. J Clin Med. 2021;10(24)doi: 10.3390/jcm10245938.
Ferrières, J., Roubille, F., Farnier, M., Jourdain, P., Angoulvant, D., Boccara, F., & Danchin, N. (2021). Control of Low-Density Lipoprotein Cholesterol in Secondary Prevention of Coronary Artery Disease in Real-Life Practice: The DAUSSET Study in French Cardiologists. Journal of clinical medicine, 10(24), . https://doi.org/10.3390/jcm10245938
Ferrières, Jean, et al. "Control of Low-Density Lipoprotein Cholesterol in Secondary Prevention of Coronary Artery Disease in Real-Life Practice: The DAUSSET Study in French Cardiologists." Journal of clinical medicine vol. 10,24 (2021). doi: https://doi.org/10.3390/jcm10245938
Ferrières J, Roubille F, Farnier M, Jourdain P, Angoulvant D, Boccara F, Danchin N. Control of Low-Density Lipoprotein Cholesterol in Secondary Prevention of Coronary Artery Disease in Real-Life Practice: The DAUSSET Study in French Cardiologists. J Clin Med. 2021 Dec 17;10(24). doi: 10.3390/jcm10245938. PMID: 34945235.
Copy Download .nbib Format: NLM
Control of Low-Density Lipoprotein Cholesterol in Secondary Prevention of Coronary Artery Disease in Real-Life Practice: The DAUSSET Study in French Cardiologists.

Journal of clinical medicine

Ferrières J, Roubille F, Farnier M, Jourdain P, Angoulvant D, Boccara F, Danchin N.
PMID: 34945235
J Clin Med. 2021 Dec 17;10(24). doi: 10.3390/jcm10245938.

INTRODUCTION: Patients with established coronary artery disease (CAD) are at very high risk for cardiovascular events.METHODS: The DAUSSET study is a national, multicenter, non-interventional study that included very high-risk CAD patients followed by French cardiologists. It aimed to describe...

Cite
Ferrières J, Roubille F, Farnier M, et al. Control of Low-Density Lipoprotein Cholesterol in Secondary Prevention of Coronary Artery Disease in Real-Life Practice: The DAUSSET Study in French Cardiologists. J Clin Med. 2021;10(24)doi: 10.3390/jcm10245938.
Ferrières, J., Roubille, F., Farnier, M., Jourdain, P., Angoulvant, D., Boccara, F., & Danchin, N. (2021). Control of Low-Density Lipoprotein Cholesterol in Secondary Prevention of Coronary Artery Disease in Real-Life Practice: The DAUSSET Study in French Cardiologists. Journal of clinical medicine, 10(24), . https://doi.org/10.3390/jcm10245938
Ferrières, Jean, et al. "Control of Low-Density Lipoprotein Cholesterol in Secondary Prevention of Coronary Artery Disease in Real-Life Practice: The DAUSSET Study in French Cardiologists." Journal of clinical medicine vol. 10,24 (2021). doi: https://doi.org/10.3390/jcm10245938
Ferrières J, Roubille F, Farnier M, Jourdain P, Angoulvant D, Boccara F, Danchin N. Control of Low-Density Lipoprotein Cholesterol in Secondary Prevention of Coronary Artery Disease in Real-Life Practice: The DAUSSET Study in French Cardiologists. J Clin Med. 2021 Dec 17;10(24). doi: 10.3390/jcm10245938. PMID: 34945235.
Copy Download .nbib Format: NLM
Showing 1 to 4 of 4 entries